138 related articles for article (PubMed ID: 15729701)
1. Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)--associated TORC1-MAML2 gene fusion.
Behboudi A; Winnes M; Gorunova L; van den Oord JJ; Mertens F; Enlund F; Stenman G
Genes Chromosomes Cancer; 2005 Jun; 43(2):202-5. PubMed ID: 15729701
[TBL] [Abstract][Full Text] [Related]
2. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene.
Behboudi A; Enlund F; Winnes M; Andrén Y; Nordkvist A; Leivo I; Flaberg E; Szekely L; Mäkitie A; Grenman R; Mark J; Stenman G
Genes Chromosomes Cancer; 2006 May; 45(5):470-81. PubMed ID: 16444749
[TBL] [Abstract][Full Text] [Related]
3. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
[TBL] [Abstract][Full Text] [Related]
4. Clear cell hidradenoma of the skin--a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion: Genes Chromosomes Cancer. 2005;43:202-205.
El-Naggar AK
Adv Anat Pathol; 2006 Mar; 13(2):80-2. PubMed ID: 16670462
[No Abstract] [Full Text] [Related]
5. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.
Coxon A; Rozenblum E; Park YS; Joshi N; Tsurutani J; Dennis PA; Kirsch IR; Kaye FJ
Cancer Res; 2005 Aug; 65(16):7137-44. PubMed ID: 16103063
[TBL] [Abstract][Full Text] [Related]
6. Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas.
Winnes M; Mölne L; Suurküla M; Andrén Y; Persson F; Enlund F; Stenman G
Genes Chromosomes Cancer; 2007 Jun; 46(6):559-63. PubMed ID: 17334997
[TBL] [Abstract][Full Text] [Related]
7. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.
Tirado Y; Williams MD; Hanna EY; Kaye FJ; Batsakis JG; El-Naggar AK
Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281
[TBL] [Abstract][Full Text] [Related]
8. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors.
Enlund F; Behboudi A; Andrén Y; Oberg C; Lendahl U; Mark J; Stenman G
Exp Cell Res; 2004 Jan; 292(1):21-8. PubMed ID: 14720503
[TBL] [Abstract][Full Text] [Related]
9. CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association.
Bell D; Luna MA; Weber RS; Kaye FJ; El-Naggar AK
Genes Chromosomes Cancer; 2008 Apr; 47(4):309-14. PubMed ID: 18181164
[TBL] [Abstract][Full Text] [Related]
10. A closer look at Warthin tumors and the t(11;19).
Fehr A; Röser K; Belge G; Löning T; Bullerdiek J
Cancer Genet Cytogenet; 2008 Jan; 180(2):135-9. PubMed ID: 18206539
[TBL] [Abstract][Full Text] [Related]
11. A new type of MAML2 fusion in mucoepidermoid carcinoma.
Fehr A; Röser K; Heidorn K; Hallas C; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2008 Mar; 47(3):203-6. PubMed ID: 18050304
[TBL] [Abstract][Full Text] [Related]
12. New insights into the nature of Warthin's tumour.
O'Neill ID
J Oral Pathol Med; 2009 Jan; 38(1):145-9. PubMed ID: 18647217
[TBL] [Abstract][Full Text] [Related]
13. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
O'Neill ID
Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
[TBL] [Abstract][Full Text] [Related]
14. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.
Okabe M; Miyabe S; Nagatsuka H; Terada A; Hanai N; Yokoi M; Shimozato K; Eimoto T; Nakamura S; Nagai N; Hasegawa Y; Inagaki H
Clin Cancer Res; 2006 Jul; 12(13):3902-7. PubMed ID: 16818685
[TBL] [Abstract][Full Text] [Related]
15. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
Tonon G; Modi S; Wu L; Kubo A; Coxon AB; Komiya T; O'Neil K; Stover K; El-Naggar A; Griffin JD; Kirsch IR; Kaye FJ
Nat Genet; 2003 Feb; 33(2):208-13. PubMed ID: 12539049
[TBL] [Abstract][Full Text] [Related]
16. t(11;19)(q21;p12~p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma.
Serra A; Schackert HK; Mohr B; Weise A; Liehr T; Fitze G
J Pediatr Surg; 2007 Jul; 42(7):E23-9. PubMed ID: 17618868
[TBL] [Abstract][Full Text] [Related]
17. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation.
Wu L; Liu J; Gao P; Nakamura M; Cao Y; Shen H; Griffin JD
EMBO J; 2005 Jul; 24(13):2391-402. PubMed ID: 15961999
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous hidradenoma: a study of 21 neoplasms revealing neither correlation between the cellular composition and CRTC1-MAML2 fusions nor presence of CRTC3-MAML2 fusions.
Kyrpychova L; Kacerovska D; Vanecek T; Grossmann P; Michal M; Kerl K; Kazakov DV
Ann Diagn Pathol; 2016 Aug; 23():8-13. PubMed ID: 27402217
[TBL] [Abstract][Full Text] [Related]
19. Oncocytic mucoepidermoid carcinoma of the parotid gland with CRTC1-MAML2 fusion transcript: report of a case with review of literature.
Fujimaki M; Fukumura Y; Saito T; Mitani K; Uchida S; Yokoyama J; Yao T; Ikeda K
Hum Pathol; 2011 Dec; 42(12):2052-5. PubMed ID: 21676434
[TBL] [Abstract][Full Text] [Related]
20. Skin-type hidradenoma of the breast parenchyma with t(11;19) translocation: hidradenoma of the breast.
Kazakov DV; Vanecek T; Belousova IE; Mukensnabl P; Kollertova D; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):457-61. PubMed ID: 17890914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
